Compare SHAK & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHAK | INSP |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.8B |
| IPO Year | 2015 | 2018 |
| Metric | SHAK | INSP |
|---|---|---|
| Price | $82.83 | $130.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 16 |
| Target Price | $119.22 | ★ $132.27 |
| AVG Volume (30 Days) | 1.5M | ★ 1.7M |
| Earning Date | 10-30-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 425.42 | 34.77 |
| EPS | 1.02 | ★ 1.48 |
| Revenue | ★ $1,373,459,000.00 | $882,622,000.00 |
| Revenue This Year | $18.47 | $14.97 |
| Revenue Next Year | $13.48 | $11.81 |
| P/E Ratio | ★ $81.39 | $88.30 |
| Revenue Growth | 13.49 | ★ 16.81 |
| 52 Week Low | $72.93 | $70.77 |
| 52 Week High | $144.65 | $216.01 |
| Indicator | SHAK | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 45.39 | 63.19 |
| Support Level | $76.51 | $132.39 |
| Resistance Level | $82.46 | $147.03 |
| Average True Range (ATR) | 3.54 | 8.60 |
| MACD | -0.15 | 0.20 |
| Stochastic Oscillator | 45.70 | 62.23 |
Shake Shack Inc is a roadside burger stand. It serves a classic American menu of premium burgers, hot dogs, crispy chicken, frozen custard, crinkle-cut fries, shakes, beer, wine and more. The company's burgers are made with a whole-muscle blend of all-natural, hormone and antibiotic-free Angus beef, ground fresh daily, cooked to order, and served on a non-genetically modified organism (GMO) potato bun. Its menu focuses on food and beverages, crafted from a range of classic American foods. The company serves draft Root Beer, seasonal freshly-squeezed lemonade, organic fresh brewed iced tea, cold brew coffee, organic apple juice, and Shack20 bottled water.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.